Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
Status:
Completed
Trial end date:
2001-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Zoledronate may help to relieve some of the symptoms caused by bone metastases. It
is not yet known if zoledronate is more effective than no further therapy in relieving
symptoms of bone metastases or preventing disease progression.
PURPOSE: Randomized phase III trial to determine the effectiveness of zoledronate in treating
patients who have solid tumors that have spread to the bone.